{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:51:14Z","timestamp":1778946674528,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:00:00Z","timestamp":1642291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:00:00Z","timestamp":1642291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Nation Science and Technology Major project of china","award":["2017ZX10302201001005"],"award-info":[{"award-number":["2017ZX10302201001005"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["81671998"],"award-info":[{"award-number":["81671998"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["81873962"],"award-info":[{"award-number":["81873962"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["32070152"],"award-info":[{"award-number":["32070152"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>Hepatitis B Virus (HBV) infection is the major risk factor for hepatocellular carcinoma (HCC) in East Asia. Here we aimed to further investigate the abundance of viral antigen and DNA within HBV-related HCC and surrounding tissues at histological level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>In addition to routine histopathology, in situ hybridization (ISH) of HBV DNA and immunohistochemistry (IHC) of HBsAg were performed in tissues from 131 HBsAg-positive HCC patients undergoing liver resection. Serum \u03b1-fetoprotein together with basic biochemical and immunological parameter was also measured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, the ISH of HBV DNA and IHC of HBsAg showed 31.3% and 92.9% positive rate respectively (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.0001). The level of correlation between these two markers was much more significant in tumor (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.0001) than in tumor-surrounding tissue (<jats:italic>p<\/jats:italic>\u00a0=\u20090.01). HBsAg exhibited a much higher positive rate in tumor-adjacent tissue than in tumor tissue (86.6% versus 29.9%, <jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.0001) with significantly different staining pattern. By contrast, the positive rate of HBV DNA ISH was comparable in tumor and surrounding tissue (17.6% versus 22.9%, <jats:italic>p<\/jats:italic>\u00a0=\u20090.36). Yet the HBV DNA signal in tumor tissue showed predominant nuclear localization (87.0%) whereas staining pattern in adjacent tissue was mixed (43.3% nuclear localization, <jats:italic>p<\/jats:italic>\u00a0=\u20090.0015). Finally, no significant association between intra-tumor HBV DNA\/HBsAg positivity and major histological markers (microvascular invasion, tumor differentiation, etc.) or recurrence after surgery was observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These data confirmed the largely integrated state of HBV DNA, weaker expression and altered localization of surface antigen in tumor compared with surrounding tissue. The strikingly different prevalence and localization of HBsAg and HBV DNA reflected the complex and heterogeneous mechanisms leading to HBV-induced tumorigenesis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-022-01194-8","type":"journal-article","created":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T07:02:26Z","timestamp":1642316546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Ye","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaonan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,16]]},"reference":[{"issue":"1","key":"1194_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. Electronic address, e.e.e. and L. European Association for the Study of the, EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182\u2013236. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.019.","journal-title":"J Hepatol"},{"issue":"4","key":"1194_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","volume":"11","author":"M Omata","year":"2017","unstructured":"Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317\u201370. https:\/\/doi.org\/10.1007\/s12072-017-9799-9.","journal-title":"Hepatol Int"},{"issue":"1 Suppl","key":"1194_CR3","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","volume":"64","author":"M Levrero","year":"2016","unstructured":"Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64(1 Suppl):S84\u2013S101. https:\/\/doi.org\/10.1016\/j.jhep.2016.02.021.","journal-title":"J Hepatol"},{"issue":"9","key":"1194_CR4","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrc1934","volume":"6","author":"PA Farazi","year":"2006","unstructured":"Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6(9):674\u201387. https:\/\/doi.org\/10.1038\/nrc1934.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"1194_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ng.2295","volume":"44","author":"WK Sung","year":"2012","unstructured":"Sung WK, Zheng H, Li S, Chen R, Liu X, Li Y, et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet. 2012;44(7):765\u20139. https:\/\/doi.org\/10.1038\/ng.2295.","journal-title":"Nat Genet"},{"issue":"1","key":"1194_CR6","doi-asserted-by":"publisher","first-page":"12992","DOI":"10.1038\/ncomms12992","volume":"7","author":"LH Zhao","year":"2016","unstructured":"Zhao LH, Liu X, Yan HX, Li WY, Zeng X, Yang Y, et al. Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun. 2016;7(1):12992. https:\/\/doi.org\/10.1038\/ncomms12992.","journal-title":"Nat Commun"},{"issue":"15","key":"1194_CR7","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380(15):1450\u201362. https:\/\/doi.org\/10.1056\/NEJMra1713263.","journal-title":"N Engl J Med"},{"issue":"6074","key":"1194_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/322070a0","volume":"322","author":"A Dejean","year":"1986","unstructured":"Dejean A, Bougueleret L, Grzeschik KH, Tiollais P. Hepatitis B virus DNA integration in a sequence homologous to v-erb-a and steroid receptor genes in a hepatocellular carcinoma. Nature. 1986;322(6074):70\u20132. https:\/\/doi.org\/10.1038\/322070a0.","journal-title":"Nature"},{"issue":"24","key":"1194_CR9","first-page":"6810","volume":"52","author":"H Yasui","year":"1992","unstructured":"Yasui H, Hino O, Ohtake K, Machinami R, Kitagawa T. Clonal growth of hepatitis B virus-integrated hepatocytes in cirrhotic liver nodules. Cancer Res. 1992;52(24):6810\u20134.","journal-title":"Cancer Res"},{"issue":"5","key":"1194_CR10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/path.1150","volume":"197","author":"Y Wang","year":"2002","unstructured":"Wang Y, Wu MC, Sham JST, Tai LS, Fang Y, Wu WQ, et al. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray. J Pathol. 2002;197(5):610\u20136. https:\/\/doi.org\/10.1002\/path.1150.","journal-title":"J Pathol"},{"issue":"4","key":"1194_CR11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1073\/pnas.0409332102","volume":"102","author":"WS Mason","year":"2005","unstructured":"Mason WS, Jilbert AR, Summers J. Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection. Proc Natl Acad Sci U S A. 2005;102(4):1139\u201344. https:\/\/doi.org\/10.1073\/pnas.0409332102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1194_CR12","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/gut.2004.054452","volume":"54","author":"Y Murakami","year":"2005","unstructured":"Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, Br\u00e9chot C, et al. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut. 2005;54(8):1162\u20138. https:\/\/doi.org\/10.1136\/gut.2004.054452.","journal-title":"Gut"},{"issue":"9","key":"1194_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/jvh.12380","volume":"22","author":"T Tu","year":"2015","unstructured":"Tu T, Mason WS, Clouston AD, Shackel NA, McCaughan GW, Yeh MM, et al. Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection. J Viral Hepat. 2015;22(9):737\u201353. https:\/\/doi.org\/10.1111\/jvh.12380.","journal-title":"J Viral Hepat"},{"issue":"5","key":"1194_CR14","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1053\/j.gastro.2016.07.012","volume":"151","author":"WS Mason","year":"2016","unstructured":"Mason WS, Gill US, Litwin S, Zhou Y, Peri S, Pop O, et al. HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant. Gastroenterology. 2016;151(5):986\u201398.e4. https:\/\/doi.org\/10.1053\/j.gastro.2016.07.012.","journal-title":"Gastroenterology"},{"issue":"3","key":"1194_CR15","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1172\/JCI83339","volume":"126","author":"X Zhang","year":"2016","unstructured":"Zhang X, Lu W, Zheng Y, Wang W, Bai L, Chen L, et al. In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection. J Clin Invest. 2016;126(3):1079\u201392. https:\/\/doi.org\/10.1172\/JCI83339.","journal-title":"J Clin Invest"},{"issue":"12","key":"1194_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/jclinpath-2020-206440","volume":"73","author":"D Liu","year":"2020","unstructured":"Liu D, Xu T, Shi B, Lu W, Zheng Y, Feng Y, et al. Clinical relevance of the in situ assay for HBV DNA: a cross-sectional study in patients with chronic hepatitis B. J Clin Pathol. 2020;73(12):813\u20138. https:\/\/doi.org\/10.1136\/jclinpath-2020-206440.","journal-title":"J Clin Pathol"},{"issue":"37","key":"1194_CR17","doi-asserted-by":"publisher","first-page":"e27220","DOI":"10.1097\/MD.0000000000027220","volume":"100","author":"C Li","year":"2021","unstructured":"Li C, Zhang W, Shi B, Chen G, Zheng Y, An Y, et al. Evaluation of the in situ assay for HBV DNA: an observational real-world study in chronic hepatitis B. Medicine (Baltimore). 2021;100(37):e27220. https:\/\/doi.org\/10.1097\/MD.0000000000027220.","journal-title":"Medicine (Baltimore)"},{"issue":"18","key":"1194_CR18","first-page":"4971","volume":"51","author":"WL Wang","year":"1991","unstructured":"Wang WL, London WT, Feitelson MA. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res. 1991;51(18):4971\u20137.","journal-title":"Cancer Res"},{"issue":"3","key":"1194_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/jmv.1890250302","volume":"25","author":"MY Lai","year":"1988","unstructured":"Lai MY, Chen DS, Chen PJ, Lee SC, Sheu JC, Huang GT, et al. Status of hepatitis B virus DNA in hepatocellular carcinoma: a study based on paired tumor and nontumor liver tissues. J Med Virol. 1988;25(3):249\u201358. https:\/\/doi.org\/10.1002\/jmv.1890250302.","journal-title":"J Med Virol"},{"issue":"18","key":"1194_CR20","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.7150\/jca.26052","volume":"9","author":"L Yang","year":"2018","unstructured":"Yang L, Ye S, Zhao X, Ji L, Zhang Y, Zhou P, et al. Molecular characterization of HBV DNA integration in patients with hepatitis and hepatocellular carcinoma. J Cancer. 2018;9(18):3225\u201335. https:\/\/doi.org\/10.7150\/jca.26052.","journal-title":"J Cancer"},{"issue":"3","key":"1194_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1073\/pnas.84.3.847","volume":"84","author":"SM Bowyer","year":"1987","unstructured":"Bowyer SM, Dusheiko GM, Schoub BD, Kew MC. Expression of the hepatitis B virus genome in chronic hepatitis B carriers and patients with hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1987;84(3):847\u201350. https:\/\/doi.org\/10.1073\/pnas.84.3.847.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1194_CR22","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1053\/j.gastro.2019.01.251","volume":"156","author":"AT Tan","year":"2019","unstructured":"Tan AT, Yang N, Lee Krishnamoorthy T, Oei V, Chua A, Zhao X, et al. Use of expression profiles of HBV-DNA integrated into genomes of hepatocellular carcinoma cells to select T cells for immunotherapy. Gastroenterology. 2019;156(6):1862\u201376.e9. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.251.","journal-title":"Gastroenterology"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-022-01194-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T19:03:02Z","timestamp":1642359782000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-022-01194-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,16]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1194"],"URL":"https:\/\/doi.org\/10.1186\/s13000-022-01194-8","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,16]]},"assertion":[{"value":"9 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the guidelines of the 2013 Declaration of Helsinki and approved by the independent ethics committee of Shanghai Public Health Clinical Center, Fudan University (2021-S003\u201301).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}